Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(0.62)
# 3,747
Out of 4,711 analysts
5
Total ratings
40%
Success rate
-12.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITOS iTeos Therapeutics | Maintains: Overweight | $31 → $19 | $7.42 | +156.06% | 2 | Dec 19, 2024 | |
| XNCR Xencor | Initiates: Overweight | $37 | $24.13 | +53.34% | 1 | Dec 12, 2024 | |
| RCUS Arcus Biosciences | Initiates: Overweight | $29 | $15.50 | +87.10% | 1 | Oct 8, 2024 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Overweight | $34 | $20.59 | +65.13% | 1 | May 3, 2024 |
iTeos Therapeutics
Dec 19, 2024
Maintains: Overweight
Price Target: $31 → $19
Current: $7.42
Upside: +156.06%
Xencor
Dec 12, 2024
Initiates: Overweight
Price Target: $37
Current: $24.13
Upside: +53.34%
Arcus Biosciences
Oct 8, 2024
Initiates: Overweight
Price Target: $29
Current: $15.50
Upside: +87.10%
Kiniksa Pharmaceuticals International,
May 3, 2024
Initiates: Overweight
Price Target: $34
Current: $20.59
Upside: +65.13%